DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ: 067080)

DAE HWA Pharmaceutical Revenue

DAE HWA Pharmaceutical had revenue of 27.42B KRW in the quarter ending March 31, 2020, with 2.61% growth. This brings the company's revenue in the last twelve months to 115.31B, up 8.65% year-over-year. In the year 2019, DAE HWA Pharmaceutical had annual revenue of 114.61B with 4.06% growth.

• Revenue (ttm): 115.31B
• Revenue Growth: +8.65%
• P/S Ratio: 2.95
• Revenue / Employee: 374.37M
• Employees: 308
• Market Cap: 341.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2019	114.61B	4.47B	4.06%
Dec 31, 2018	110.14B	-12.06B	-9.87%
Dec 31, 2017	122.20B	-20.09B	-14.12%
Dec 31, 2016	142.29B	3.21B	2.31%
Dec 31, 2015	139.08B	4.15B	3.08%